Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IRPilo) in comparison with its original brand-name drug (Vuity). Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients r...
Saved in:
Main Authors: | Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli- Monfared, Kourosh Sheibani, Hemn Baghban Jaldian |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2024-12-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | https://knepublishing.com/index.php/JOVR/article/view/14578 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination Low-Dose Pilocarpine/Diclofenac Sodium and Pilocarpine Alone for Presbyopia: Results of a Randomized Phase 2b Clinical Trial
by: Farid M, et al.
Published: (2024-11-01) -
An updated systematic review of pharmacological treatments for presbyopia
by: Andrzej Grzybowski, et al.
Published: (2024-11-01) -
Efficacy and Safety of Pilocarpine Eye Drops Combinations for Treating Presbyopia in a Thai Population: A Randomized Crossover Trial
by: Thammanoon Surachatkumtonekul, et al.
Published: (2024-10-01) -
Psychological empowerment after presbyopia correction: A narrative from Zanzibari women and men
by: Christine Graham, et al.
Published: (2025-04-01) -
Influences of AC/A ratio and accommodation facility on near vision in presbyopic individuals: A prospective study done on North Indian population by comparing the presbyopic glass users with nonglass users
by: Amit Kumar Jain, et al.
Published: (2025-01-01)